Global Skin Grafting Market by Graft Type (Autograft, Allograft, Xenograft, Isograft, and Prosthetic Graft), Product (Graft Mesher, Dermatome, and Wound Debridement Devices, Others), Application (Burns, Surgical Wounds, Traumatic Wounds, and Chronic Wounds, Others), and End User (Hospitals & Clinics, Research Institutes, and Ambulatory Surgical Centers) – Global Outlook & Forecast 2022-2030
According to the deep-dive market assessment study conducted by Growth+Reports, the global skin grafting market was pegged at ~US$ 4.1 billion in 2021. The market is expected to witness a CAGR of ~6.9% from 2022 to 2030.
Skin grafting is a surgical procedure that restores and replaces the injured or diseased skin using healthy donor. Skin grafting is used in different wound indications such as deep burns, injury, skin cancer or reconstructive surgeries, and skin diseases. This process helps to recover the disfigured skin caused due to any physical trauma by replacing the damaged layer of the skin or tissue.Growing incidences of different conditions like skin cancer, diabetes, necrotizing fasciitis, and burn injuries that require removal or repair of damaged skin; rising application of skin grafting in surgeries; technological advancement in skin grafting; and favorable reimbursement policies are some of the prime factors propelling the growth of the skin grafting market.
Government bodies and numerous organizations across the globe are implementing several initiatives to fast-track the development of skin grafts by providing the necessary funding, grants, permissions, clearances & approvals to meet the needs of the healthcare sector. For instance, in October 2021, Kerecis received the US Food and Drug Administration (FDA) marketing authorization for its Omega3 SurgiBind, an implantable fish-skin graft intended for use in plastic and reconstructive surgery.
Also, technological advancement and evolution in dermatomes like the manufacturing of electric and air dermatomes with improved precision are the key points that are expected to boost the market for skin grafting. For instance, research conducted at University of Arkansas for Medical Sciences (UAMS) has developed a new variant of advanced dermatomes. These new and enhanced dermatomes provide many benefits, such as a battery operation for better patient safety with reduced time requirements. Furthermore, it is very convenient for physicians to use,
allowing easy, smooth, and precise application due to its modified design according to the requirements of the skin grafting procedure. Thus, growth in the adoption rate of technological advanced instruments contributes to the development of skin grafting market.
The rising number of burn injuries has pushed the healthcare system to implement burn care programs and management services. For an instance, according to the Children’s Safety Network (CSN) report which was published in 2021, nearly 300 children and adolescents die because of severe burn injuries each year. While more than 100,000 get treated in the emergency ward due to deep and severe burns in the hospital every year. Thus, rising cases of burn incidences fuels the market development.
However, the complications in skin grafting procedure and cost associated with this treatment are likely to restrain market growth to a certain extent. The cost of this procedure can be to a major challenge for skin grafting market. The expensive procedure can lower the patient base for skin grafting procedure, thereby adversely impacting the skin grafting market growth.
Based on regions, the global skin grafting market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America will be leading the skin graft market, owing to suitable reimbursement scenario and large healthcare expenditure. In addition, significantly high adoption of new and advanced treatment technologies in the United States will be another strong factor that will drive the growth in the skin grafting industry.. While, Asia Pacific (APAC) is fastest-growing region in terms of market growth. This growth can be attributed to large patient base for burn-cases and development in the healthcare infrastructure.
In addition, the growing demand for skin grafts to treat skin diseases like cancer, as well as government initiatives for patients suffering burn injury prevention and control programs, are driving market growth in the Asia Pacific region. Other factors driving the skin grafting market in Asia Pacific are increasing awareness in the general population, growing skills of surgeons and healthcare expenditure.
Some of the prominent players operating in the global skin grafting market are Zimmer Biomet, B. Braun Melsungen AG, Integra LifeScience, MIMEDX, Smith+Nephew, Nouvag AG, Exsurco Medical, Inc., Rudolf Storz GmbH., De Soutter Medical, and AVITA Medical among others.